Human Metabolome Technologies, Inc. announced consolidated earnings results for the third quarter ended March 2020. For the period, the company reported net sales of JPY 993 million, operating loss was JPY 128 million, profit attributable to the owners of parent was JPY 88 million and basic loss per share was JPY 15.05.

For the year ending June 30, 2020, the company expects consolidated net sales to be JPY 1,110 million, operating loss to be JPY 56 million, loss attributable to owners of parent to be JPY 85 million and basic loss per share to be JPY 9.90.